Charles Fletcher Payne

Charles Fletcher Payne is a declared insider of Aptose Biosciences Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 27 June 2022 to 18 February 2025, the count stands at 8 filings.

Every open-market trade on record is a purchase: 1 purchase worth €5,100, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 option exercise.

The newest entry dates from 9 April 2025: a transaction, in Aptose Biosciences Inc. The latest purchase dates back some time: it was published 1,495 days ago, on 22 September 2022. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.